Keppra (levetiracetam) is an anti-seizure medication used to treat epilepsy. It is approved for three specific types of seizures: partial-onset seizures, myoclonic seizures in juvenile myoclonic epilepsy, and primary generalized tonic-clonic seizures. It works differently from older seizure medications and has become one of the most widely prescribed options because of its favorable interaction profile and relatively mild side effects.
Types of Seizures Keppra Treats
Keppra has three distinct FDA-approved uses, each covering a different seizure type and age range.
Partial-onset seizures are the most common reason Keppra is prescribed. These seizures start in one area of the brain and may or may not spread to both sides. Keppra can be used on its own or alongside other medications for this type, in patients as young as 1 month old.
Myoclonic seizures cause sudden, brief muscle jerks, often in the arms or shoulders. Keppra is approved as an add-on treatment for people 12 and older who have juvenile myoclonic epilepsy, a form of epilepsy that typically begins in adolescence.
Primary generalized tonic-clonic seizures are what most people picture when they think of a seizure: stiffening of the body followed by rhythmic jerking. Keppra is approved as an add-on treatment for patients 6 and older with idiopathic generalized epilepsy, a type of epilepsy without a known structural cause in the brain.
How Keppra Works
Keppra has a mechanism unlike any other seizure medication. It binds to a protein called SV2A that sits on the surface of tiny sacs (vesicles) inside nerve cells. These vesicles store chemical messengers and release them when a nerve fires. By attaching to SV2A, Keppra appears to regulate the release of those chemical signals, dampening the excessive electrical activity that causes seizures.
Because it works through this unique pathway rather than through the sodium or calcium channels that most other anti-seizure drugs target, Keppra is often effective in people who haven’t responded well to other medications. It also means Keppra doesn’t compete with those drugs at the same molecular sites, making it a good candidate for combination therapy.
How Quickly It Works and How Long It Lasts
Keppra is absorbed rapidly after you take it by mouth. Blood levels typically peak within about one hour in both adults and children. The drug’s half-life in adults is roughly 7 hours, meaning it takes about that long for your body to clear half the dose. This is why the standard tablet is taken twice daily, roughly 12 hours apart. An extended-release version is available that can be taken once a day.
Typical Dosing
Adults and teenagers 16 and older usually start at 500 mg twice a day. The dose can be increased over time, but the maximum is generally 3,000 mg per day. For the extended-release tablet, the starting dose is 1,000 mg once daily in adults and children 12 and older who weigh at least 50 kg (about 110 pounds).
Children’s doses are based on body weight. Kids aged 4 to 15 typically start at 10 mg per kilogram of body weight, taken twice daily, with a maximum of 60 mg per kilogram per day. Doses for children under 4 are determined individually. Keppra also comes as a liquid solution, which makes dosing easier for young children and infants.
Why Keppra Has Few Drug Interactions
One of Keppra’s biggest practical advantages is that it rarely interferes with other medications. Most drugs are broken down by a family of liver enzymes known as the cytochrome P450 system. Keppra bypasses this system almost entirely. Its main metabolic pathway is a simple chemical reaction (hydrolysis) carried out by a different type of enzyme, and only about 24% of the dose is metabolized this way. The rest is eliminated unchanged by the kidneys.
This matters if you take other medications. Many older anti-seizure drugs speed up or slow down the P450 enzymes, which can change how birth control pills, blood thinners, and dozens of other common drugs work in your body. Keppra doesn’t do this. It neither inhibits nor activates those enzymes at therapeutic doses, making it much simpler to combine with other treatments.
Kidney Function and Dose Adjustments
Because Keppra is cleared primarily through the kidneys rather than the liver, reduced kidney function means the drug stays in your body longer. In people with moderate kidney impairment, clearance drops by about 60%, so the dose needs to be lowered accordingly. People on dialysis face the steepest adjustment: Keppra’s half-life stretches to around 25 hours between dialysis sessions, and a standard 4-hour dialysis session removes roughly half of the drug. A supplemental dose after dialysis is typically needed to maintain effective levels.
Safety During Pregnancy
For people with epilepsy who become pregnant, the safety of their medication is a major concern. Keppra has one of the more reassuring safety profiles among anti-seizure drugs. A systematic review covering over 1,200 pregnancies exposed to Keppra alone found a major malformation rate of 2.2%, which falls within the 1% to 3% baseline risk seen in the general population. No apparent adverse effects on long-term child development have been identified.
The picture changes when Keppra is combined with other anti-seizure drugs. In those cases, the malformation rate rises to about 6.3%, though it’s difficult to separate Keppra’s contribution from the effects of the other medications. This is one reason neurologists often try to simplify a patient’s medication regimen before or during pregnancy when possible.
Common Side Effects
The most frequently reported side effects of Keppra are drowsiness, fatigue, dizziness, and weakness, particularly when first starting the medication or after a dose increase. These tend to improve over the first few weeks as your body adjusts.
Behavioral and mood changes are the side effects that get the most attention. Some people experience irritability, agitation, or mood swings. In children these behavioral shifts can be more noticeable. Starting at a lower dose and increasing gradually can help reduce the likelihood and severity of these effects. If mood changes become significant, there are alternative medications your prescriber can consider.
Off-Label Uses
While Keppra is approved specifically for epilepsy, it is sometimes prescribed off-label for other conditions involving abnormal electrical activity in the brain. These include preventing seizures after traumatic brain injury or neurosurgery, and occasionally for certain types of movement disorders. Its favorable safety profile and minimal drug interactions make it a practical choice in complex medical situations where patients are already taking multiple medications.